Global Antiserum Supply, Demand and Key Producers, 2023-2029
The global Antiserum market size is expected to reach $ 2067.2 million by 2029, rising at a market growth of 6.5% CAGR during the forecast period (2023-2029).
Global 5 largest manufacturers of Antiserum are CSL, Merck, BTG, Pfizer and CNBG, which make up over 58%. Among them, CSL is the leader with about 16% market share.
Asia-Pacific is the largest market, with a share about 47%, followed by North America and Middle East and Africa, with the share about 24% and 12%. In terms of product type, Antitoxin Serum occupies the largest share of the total market, about 61%. And in terms of application, the largest application is Clinical, followed by Laboratory.
Antiserum, is a type of blood serum that contains specific antibodies against an antigen (foreign agent), such as an infective organism or poisonous substance. Antibodies in antiserum work by detecting and subsequently neutralizing antigens.
Antiserums are produced in animals, most commonly horses, sheep, oxen, and rabbits, and in humans, in response to infection, intoxication, or vaccination. Animal and human antiserums can be used in other individuals to confer immunity to a specific disease or to treat bites or stings of venomous animals.
Antiserum widely used in diagnostic virology laboratories. The most common use of antiserum in humans is as antitoxin or antivenom to treat envenomation.
This report studies the global Antiserum demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Antiserum, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Antiserum that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Antiserum total market, 2018-2029, (USD Million)
Global Antiserum total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: Antiserum total market, key domestic companies and share, (USD Million)
Global Antiserum revenue by player and market share 2018-2023, (USD Million)
Global Antiserum total market by Type, CAGR, 2018-2029, (USD Million)
Global Antiserum total market by Application, CAGR, 2018-2029, (USD Million).
This reports profiles major players in the global Antiserum market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include BD, Bio-Rad, Shanghai Serum Bio-Technology Co., Ltd., China National Pharmaceutical Group, CSL, Merck, BTG, Pfizer and Haffkine Bio-Pharmaceutical, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Antiserum market.
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Antiserum Market, By Region:
1. How big is the global Antiserum market?
2. What is the demand of the global Antiserum market?
3. What is the year over year growth of the global Antiserum market?
4. What is the total value of the global Antiserum market?
5. Who are the major players in the global Antiserum market?
6. What are the growth factors driving the market demand?
Global 5 largest manufacturers of Antiserum are CSL, Merck, BTG, Pfizer and CNBG, which make up over 58%. Among them, CSL is the leader with about 16% market share.
Asia-Pacific is the largest market, with a share about 47%, followed by North America and Middle East and Africa, with the share about 24% and 12%. In terms of product type, Antitoxin Serum occupies the largest share of the total market, about 61%. And in terms of application, the largest application is Clinical, followed by Laboratory.
Antiserum, is a type of blood serum that contains specific antibodies against an antigen (foreign agent), such as an infective organism or poisonous substance. Antibodies in antiserum work by detecting and subsequently neutralizing antigens.
Antiserums are produced in animals, most commonly horses, sheep, oxen, and rabbits, and in humans, in response to infection, intoxication, or vaccination. Animal and human antiserums can be used in other individuals to confer immunity to a specific disease or to treat bites or stings of venomous animals.
Antiserum widely used in diagnostic virology laboratories. The most common use of antiserum in humans is as antitoxin or antivenom to treat envenomation.
This report studies the global Antiserum demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Antiserum, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Antiserum that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Antiserum total market, 2018-2029, (USD Million)
Global Antiserum total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: Antiserum total market, key domestic companies and share, (USD Million)
Global Antiserum revenue by player and market share 2018-2023, (USD Million)
Global Antiserum total market by Type, CAGR, 2018-2029, (USD Million)
Global Antiserum total market by Application, CAGR, 2018-2029, (USD Million).
This reports profiles major players in the global Antiserum market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include BD, Bio-Rad, Shanghai Serum Bio-Technology Co., Ltd., China National Pharmaceutical Group, CSL, Merck, BTG, Pfizer and Haffkine Bio-Pharmaceutical, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Antiserum market.
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Antiserum Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Antitoxin Serum
- Antibacterial Serum
- Antiviral Serum
- Others
- Clinical
- Laboratory
- BD
- Bio-Rad
- Shanghai Serum Bio-Technology Co., Ltd.
- China National Pharmaceutical Group
- CSL
- Merck
- BTG
- Pfizer
- Haffkine Bio-Pharmaceutical
- Vins Bioproducts
- Bharat Serums and Vaccines
- SSI Diagnostica
- GD Animal Health
- MicroPharm
- Peptide Institute Inc.
- Rare Disease Therapeutics
1. How big is the global Antiserum market?
2. What is the demand of the global Antiserum market?
3. What is the year over year growth of the global Antiserum market?
4. What is the total value of the global Antiserum market?
5. Who are the major players in the global Antiserum market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Antiserum Introduction
1.2 World Antiserum Market Size & Forecast (2018 & 2022 & 2029)
1.3 World Antiserum Total Market by Region (by Headquarter Location)
1.3.1 World Antiserum Market Size by Region (2018-2029), (by Headquarter Location)
1.3.2 United States Antiserum Market Size (2018-2029)
1.3.3 China Antiserum Market Size (2018-2029)
1.3.4 Europe Antiserum Market Size (2018-2029)
1.3.5 Japan Antiserum Market Size (2018-2029)
1.3.6 South Korea Antiserum Market Size (2018-2029)
1.3.7 ASEAN Antiserum Market Size (2018-2029)
1.3.8 India Antiserum Market Size (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Antiserum Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Antiserum Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Antiserum Consumption Value (2018-2029)
2.2 World Antiserum Consumption Value by Region
2.2.1 World Antiserum Consumption Value by Region (2018-2023)
2.2.2 World Antiserum Consumption Value Forecast by Region (2024-2029)
2.3 United States Antiserum Consumption Value (2018-2029)
2.4 China Antiserum Consumption Value (2018-2029)
2.5 Europe Antiserum Consumption Value (2018-2029)
2.6 Japan Antiserum Consumption Value (2018-2029)
2.7 South Korea Antiserum Consumption Value (2018-2029)
2.8 ASEAN Antiserum Consumption Value (2018-2029)
2.9 India Antiserum Consumption Value (2018-2029)
3 WORLD ANTISERUM COMPANIES COMPETITIVE ANALYSIS
3.1 World Antiserum Revenue by Player (2018-2023)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Antiserum Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Antiserum in 2022
3.2.3 Global Concentration Ratios (CR8) for Antiserum in 2022
3.3 Antiserum Company Evaluation Quadrant
3.4 Antiserum Market: Overall Company Footprint Analysis
3.4.1 Antiserum Market: Region Footprint
3.4.2 Antiserum Market: Company Product Type Footprint
3.4.3 Antiserum Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF THE WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Antiserum Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Antiserum Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
4.1.2 United States VS China: Antiserum Revenue Market Share Comparison (2018 & 2022 & 2029)
4.2 United States Based Companies VS China Based Companies: Antiserum Consumption Value Comparison
4.2.1 United States VS China: Antiserum Consumption Value Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Antiserum Consumption Value Market Share Comparison (2018 & 2022 & 2029)
4.3 United States Based Antiserum Companies and Market Share, 2018-2023
4.3.1 United States Based Antiserum Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Antiserum Revenue, (2018-2023)
4.4 China Based Companies Antiserum Revenue and Market Share, 2018-2023
4.4.1 China Based Antiserum Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Antiserum Revenue, (2018-2023)
4.5 Rest of World Based Antiserum Companies and Market Share, 2018-2023
4.5.1 Rest of World Based Antiserum Companies, Headquarters (States, Country)
4.5.2 Rest of World Based Companies Antiserum Revenue, (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Antiserum Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Antitoxin Serum
5.2.2 Antibacterial Serum
5.2.3 Antiviral Serum
5.2.4 Others
5.3 Market Segment by Type
5.3.1 World Antiserum Market Size by Type (2018-2023)
5.3.2 World Antiserum Market Size by Type (2024-2029)
5.3.3 World Antiserum Market Size Market Share by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Antiserum Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Clinical
6.2.2 Laboratory
6.3 Market Segment by Application
6.3.1 World Antiserum Market Size by Application (2018-2023)
6.3.2 World Antiserum Market Size by Application (2024-2029)
6.3.3 World Antiserum Market Size by Application (2018-2029)
7 COMPANY PROFILES
7.1 BD
7.1.1 BD Details
7.1.2 BD Major Business
7.1.3 BD Antiserum Product and Services
7.1.4 BD Antiserum Revenue, Gross Margin and Market Share (2018-2023)
7.1.5 BD Recent Developments/Updates
7.1.6 BD Competitive Strengths & Weaknesses
7.2 Bio-Rad
7.2.1 Bio-Rad Details
7.2.2 Bio-Rad Major Business
7.2.3 Bio-Rad Antiserum Product and Services
7.2.4 Bio-Rad Antiserum Revenue, Gross Margin and Market Share (2018-2023)
7.2.5 Bio-Rad Recent Developments/Updates
7.2.6 Bio-Rad Competitive Strengths & Weaknesses
7.3 Shanghai Serum Bio-Technology Co., Ltd.
7.3.1 Shanghai Serum Bio-Technology Co., Ltd. Details
7.3.2 Shanghai Serum Bio-Technology Co., Ltd. Major Business
7.3.3 Shanghai Serum Bio-Technology Co., Ltd. Antiserum Product and Services
7.3.4 Shanghai Serum Bio-Technology Co., Ltd. Antiserum Revenue, Gross Margin and Market Share (2018-2023)
7.3.5 Shanghai Serum Bio-Technology Co., Ltd. Recent Developments/Updates
7.3.6 Shanghai Serum Bio-Technology Co., Ltd. Competitive Strengths & Weaknesses
7.4 China National Pharmaceutical Group
7.4.1 China National Pharmaceutical Group Details
7.4.2 China National Pharmaceutical Group Major Business
7.4.3 China National Pharmaceutical Group Antiserum Product and Services
7.4.4 China National Pharmaceutical Group Antiserum Revenue, Gross Margin and Market Share (2018-2023)
7.4.5 China National Pharmaceutical Group Recent Developments/Updates
7.4.6 China National Pharmaceutical Group Competitive Strengths & Weaknesses
7.5 CSL
7.5.1 CSL Details
7.5.2 CSL Major Business
7.5.3 CSL Antiserum Product and Services
7.5.4 CSL Antiserum Revenue, Gross Margin and Market Share (2018-2023)
7.5.5 CSL Recent Developments/Updates
7.5.6 CSL Competitive Strengths & Weaknesses
7.6 Merck
7.6.1 Merck Details
7.6.2 Merck Major Business
7.6.3 Merck Antiserum Product and Services
7.6.4 Merck Antiserum Revenue, Gross Margin and Market Share (2018-2023)
7.6.5 Merck Recent Developments/Updates
7.6.6 Merck Competitive Strengths & Weaknesses
7.7 BTG
7.7.1 BTG Details
7.7.2 BTG Major Business
7.7.3 BTG Antiserum Product and Services
7.7.4 BTG Antiserum Revenue, Gross Margin and Market Share (2018-2023)
7.7.5 BTG Recent Developments/Updates
7.7.6 BTG Competitive Strengths & Weaknesses
7.8 Pfizer
7.8.1 Pfizer Details
7.8.2 Pfizer Major Business
7.8.3 Pfizer Antiserum Product and Services
7.8.4 Pfizer Antiserum Revenue, Gross Margin and Market Share (2018-2023)
7.8.5 Pfizer Recent Developments/Updates
7.8.6 Pfizer Competitive Strengths & Weaknesses
7.9 Haffkine Bio-Pharmaceutical
7.9.1 Haffkine Bio-Pharmaceutical Details
7.9.2 Haffkine Bio-Pharmaceutical Major Business
7.9.3 Haffkine Bio-Pharmaceutical Antiserum Product and Services
7.9.4 Haffkine Bio-Pharmaceutical Antiserum Revenue, Gross Margin and Market Share (2018-2023)
7.9.5 Haffkine Bio-Pharmaceutical Recent Developments/Updates
7.9.6 Haffkine Bio-Pharmaceutical Competitive Strengths & Weaknesses
7.10 Vins Bioproducts
7.10.1 Vins Bioproducts Details
7.10.2 Vins Bioproducts Major Business
7.10.3 Vins Bioproducts Antiserum Product and Services
7.10.4 Vins Bioproducts Antiserum Revenue, Gross Margin and Market Share (2018-2023)
7.10.5 Vins Bioproducts Recent Developments/Updates
7.10.6 Vins Bioproducts Competitive Strengths & Weaknesses
7.11 Bharat Serums and Vaccines
7.11.1 Bharat Serums and Vaccines Details
7.11.2 Bharat Serums and Vaccines Major Business
7.11.3 Bharat Serums and Vaccines Antiserum Product and Services
7.11.4 Bharat Serums and Vaccines Antiserum Revenue, Gross Margin and Market Share (2018-2023)
7.11.5 Bharat Serums and Vaccines Recent Developments/Updates
7.11.6 Bharat Serums and Vaccines Competitive Strengths & Weaknesses
7.12 SSI Diagnostica
7.12.1 SSI Diagnostica Details
7.12.2 SSI Diagnostica Major Business
7.12.3 SSI Diagnostica Antiserum Product and Services
7.12.4 SSI Diagnostica Antiserum Revenue, Gross Margin and Market Share (2018-2023)
7.12.5 SSI Diagnostica Recent Developments/Updates
7.12.6 SSI Diagnostica Competitive Strengths & Weaknesses
7.13 GD Animal Health
7.13.1 GD Animal Health Details
7.13.2 GD Animal Health Major Business
7.13.3 GD Animal Health Antiserum Product and Services
7.13.4 GD Animal Health Antiserum Revenue, Gross Margin and Market Share (2018-2023)
7.13.5 GD Animal Health Recent Developments/Updates
7.13.6 GD Animal Health Competitive Strengths & Weaknesses
7.14 MicroPharm
7.14.1 MicroPharm Details
7.14.2 MicroPharm Major Business
7.14.3 MicroPharm Antiserum Product and Services
7.14.4 MicroPharm Antiserum Revenue, Gross Margin and Market Share (2018-2023)
7.14.5 MicroPharm Recent Developments/Updates
7.14.6 MicroPharm Competitive Strengths & Weaknesses
7.15 Peptide Institute Inc.
7.15.1 Peptide Institute Inc. Details
7.15.2 Peptide Institute Inc. Major Business
7.15.3 Peptide Institute Inc. Antiserum Product and Services
7.15.4 Peptide Institute Inc. Antiserum Revenue, Gross Margin and Market Share (2018-2023)
7.15.5 Peptide Institute Inc. Recent Developments/Updates
7.15.6 Peptide Institute Inc. Competitive Strengths & Weaknesses
7.16 Rare Disease Therapeutics
7.16.1 Rare Disease Therapeutics Details
7.16.2 Rare Disease Therapeutics Major Business
7.16.3 Rare Disease Therapeutics Antiserum Product and Services
7.16.4 Rare Disease Therapeutics Antiserum Revenue, Gross Margin and Market Share (2018-2023)
7.16.5 Rare Disease Therapeutics Recent Developments/Updates
7.16.6 Rare Disease Therapeutics Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Antiserum Industry Chain
8.2 Antiserum Upstream Analysis
8.3 Antiserum Midstream Analysis
8.4 Antiserum Downstream Analysis
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
1.1 Antiserum Introduction
1.2 World Antiserum Market Size & Forecast (2018 & 2022 & 2029)
1.3 World Antiserum Total Market by Region (by Headquarter Location)
1.3.1 World Antiserum Market Size by Region (2018-2029), (by Headquarter Location)
1.3.2 United States Antiserum Market Size (2018-2029)
1.3.3 China Antiserum Market Size (2018-2029)
1.3.4 Europe Antiserum Market Size (2018-2029)
1.3.5 Japan Antiserum Market Size (2018-2029)
1.3.6 South Korea Antiserum Market Size (2018-2029)
1.3.7 ASEAN Antiserum Market Size (2018-2029)
1.3.8 India Antiserum Market Size (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Antiserum Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Antiserum Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Antiserum Consumption Value (2018-2029)
2.2 World Antiserum Consumption Value by Region
2.2.1 World Antiserum Consumption Value by Region (2018-2023)
2.2.2 World Antiserum Consumption Value Forecast by Region (2024-2029)
2.3 United States Antiserum Consumption Value (2018-2029)
2.4 China Antiserum Consumption Value (2018-2029)
2.5 Europe Antiserum Consumption Value (2018-2029)
2.6 Japan Antiserum Consumption Value (2018-2029)
2.7 South Korea Antiserum Consumption Value (2018-2029)
2.8 ASEAN Antiserum Consumption Value (2018-2029)
2.9 India Antiserum Consumption Value (2018-2029)
3 WORLD ANTISERUM COMPANIES COMPETITIVE ANALYSIS
3.1 World Antiserum Revenue by Player (2018-2023)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Antiserum Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Antiserum in 2022
3.2.3 Global Concentration Ratios (CR8) for Antiserum in 2022
3.3 Antiserum Company Evaluation Quadrant
3.4 Antiserum Market: Overall Company Footprint Analysis
3.4.1 Antiserum Market: Region Footprint
3.4.2 Antiserum Market: Company Product Type Footprint
3.4.3 Antiserum Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF THE WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Antiserum Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Antiserum Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
4.1.2 United States VS China: Antiserum Revenue Market Share Comparison (2018 & 2022 & 2029)
4.2 United States Based Companies VS China Based Companies: Antiserum Consumption Value Comparison
4.2.1 United States VS China: Antiserum Consumption Value Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Antiserum Consumption Value Market Share Comparison (2018 & 2022 & 2029)
4.3 United States Based Antiserum Companies and Market Share, 2018-2023
4.3.1 United States Based Antiserum Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Antiserum Revenue, (2018-2023)
4.4 China Based Companies Antiserum Revenue and Market Share, 2018-2023
4.4.1 China Based Antiserum Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Antiserum Revenue, (2018-2023)
4.5 Rest of World Based Antiserum Companies and Market Share, 2018-2023
4.5.1 Rest of World Based Antiserum Companies, Headquarters (States, Country)
4.5.2 Rest of World Based Companies Antiserum Revenue, (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Antiserum Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Antitoxin Serum
5.2.2 Antibacterial Serum
5.2.3 Antiviral Serum
5.2.4 Others
5.3 Market Segment by Type
5.3.1 World Antiserum Market Size by Type (2018-2023)
5.3.2 World Antiserum Market Size by Type (2024-2029)
5.3.3 World Antiserum Market Size Market Share by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Antiserum Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Clinical
6.2.2 Laboratory
6.3 Market Segment by Application
6.3.1 World Antiserum Market Size by Application (2018-2023)
6.3.2 World Antiserum Market Size by Application (2024-2029)
6.3.3 World Antiserum Market Size by Application (2018-2029)
7 COMPANY PROFILES
7.1 BD
7.1.1 BD Details
7.1.2 BD Major Business
7.1.3 BD Antiserum Product and Services
7.1.4 BD Antiserum Revenue, Gross Margin and Market Share (2018-2023)
7.1.5 BD Recent Developments/Updates
7.1.6 BD Competitive Strengths & Weaknesses
7.2 Bio-Rad
7.2.1 Bio-Rad Details
7.2.2 Bio-Rad Major Business
7.2.3 Bio-Rad Antiserum Product and Services
7.2.4 Bio-Rad Antiserum Revenue, Gross Margin and Market Share (2018-2023)
7.2.5 Bio-Rad Recent Developments/Updates
7.2.6 Bio-Rad Competitive Strengths & Weaknesses
7.3 Shanghai Serum Bio-Technology Co., Ltd.
7.3.1 Shanghai Serum Bio-Technology Co., Ltd. Details
7.3.2 Shanghai Serum Bio-Technology Co., Ltd. Major Business
7.3.3 Shanghai Serum Bio-Technology Co., Ltd. Antiserum Product and Services
7.3.4 Shanghai Serum Bio-Technology Co., Ltd. Antiserum Revenue, Gross Margin and Market Share (2018-2023)
7.3.5 Shanghai Serum Bio-Technology Co., Ltd. Recent Developments/Updates
7.3.6 Shanghai Serum Bio-Technology Co., Ltd. Competitive Strengths & Weaknesses
7.4 China National Pharmaceutical Group
7.4.1 China National Pharmaceutical Group Details
7.4.2 China National Pharmaceutical Group Major Business
7.4.3 China National Pharmaceutical Group Antiserum Product and Services
7.4.4 China National Pharmaceutical Group Antiserum Revenue, Gross Margin and Market Share (2018-2023)
7.4.5 China National Pharmaceutical Group Recent Developments/Updates
7.4.6 China National Pharmaceutical Group Competitive Strengths & Weaknesses
7.5 CSL
7.5.1 CSL Details
7.5.2 CSL Major Business
7.5.3 CSL Antiserum Product and Services
7.5.4 CSL Antiserum Revenue, Gross Margin and Market Share (2018-2023)
7.5.5 CSL Recent Developments/Updates
7.5.6 CSL Competitive Strengths & Weaknesses
7.6 Merck
7.6.1 Merck Details
7.6.2 Merck Major Business
7.6.3 Merck Antiserum Product and Services
7.6.4 Merck Antiserum Revenue, Gross Margin and Market Share (2018-2023)
7.6.5 Merck Recent Developments/Updates
7.6.6 Merck Competitive Strengths & Weaknesses
7.7 BTG
7.7.1 BTG Details
7.7.2 BTG Major Business
7.7.3 BTG Antiserum Product and Services
7.7.4 BTG Antiserum Revenue, Gross Margin and Market Share (2018-2023)
7.7.5 BTG Recent Developments/Updates
7.7.6 BTG Competitive Strengths & Weaknesses
7.8 Pfizer
7.8.1 Pfizer Details
7.8.2 Pfizer Major Business
7.8.3 Pfizer Antiserum Product and Services
7.8.4 Pfizer Antiserum Revenue, Gross Margin and Market Share (2018-2023)
7.8.5 Pfizer Recent Developments/Updates
7.8.6 Pfizer Competitive Strengths & Weaknesses
7.9 Haffkine Bio-Pharmaceutical
7.9.1 Haffkine Bio-Pharmaceutical Details
7.9.2 Haffkine Bio-Pharmaceutical Major Business
7.9.3 Haffkine Bio-Pharmaceutical Antiserum Product and Services
7.9.4 Haffkine Bio-Pharmaceutical Antiserum Revenue, Gross Margin and Market Share (2018-2023)
7.9.5 Haffkine Bio-Pharmaceutical Recent Developments/Updates
7.9.6 Haffkine Bio-Pharmaceutical Competitive Strengths & Weaknesses
7.10 Vins Bioproducts
7.10.1 Vins Bioproducts Details
7.10.2 Vins Bioproducts Major Business
7.10.3 Vins Bioproducts Antiserum Product and Services
7.10.4 Vins Bioproducts Antiserum Revenue, Gross Margin and Market Share (2018-2023)
7.10.5 Vins Bioproducts Recent Developments/Updates
7.10.6 Vins Bioproducts Competitive Strengths & Weaknesses
7.11 Bharat Serums and Vaccines
7.11.1 Bharat Serums and Vaccines Details
7.11.2 Bharat Serums and Vaccines Major Business
7.11.3 Bharat Serums and Vaccines Antiserum Product and Services
7.11.4 Bharat Serums and Vaccines Antiserum Revenue, Gross Margin and Market Share (2018-2023)
7.11.5 Bharat Serums and Vaccines Recent Developments/Updates
7.11.6 Bharat Serums and Vaccines Competitive Strengths & Weaknesses
7.12 SSI Diagnostica
7.12.1 SSI Diagnostica Details
7.12.2 SSI Diagnostica Major Business
7.12.3 SSI Diagnostica Antiserum Product and Services
7.12.4 SSI Diagnostica Antiserum Revenue, Gross Margin and Market Share (2018-2023)
7.12.5 SSI Diagnostica Recent Developments/Updates
7.12.6 SSI Diagnostica Competitive Strengths & Weaknesses
7.13 GD Animal Health
7.13.1 GD Animal Health Details
7.13.2 GD Animal Health Major Business
7.13.3 GD Animal Health Antiserum Product and Services
7.13.4 GD Animal Health Antiserum Revenue, Gross Margin and Market Share (2018-2023)
7.13.5 GD Animal Health Recent Developments/Updates
7.13.6 GD Animal Health Competitive Strengths & Weaknesses
7.14 MicroPharm
7.14.1 MicroPharm Details
7.14.2 MicroPharm Major Business
7.14.3 MicroPharm Antiserum Product and Services
7.14.4 MicroPharm Antiserum Revenue, Gross Margin and Market Share (2018-2023)
7.14.5 MicroPharm Recent Developments/Updates
7.14.6 MicroPharm Competitive Strengths & Weaknesses
7.15 Peptide Institute Inc.
7.15.1 Peptide Institute Inc. Details
7.15.2 Peptide Institute Inc. Major Business
7.15.3 Peptide Institute Inc. Antiserum Product and Services
7.15.4 Peptide Institute Inc. Antiserum Revenue, Gross Margin and Market Share (2018-2023)
7.15.5 Peptide Institute Inc. Recent Developments/Updates
7.15.6 Peptide Institute Inc. Competitive Strengths & Weaknesses
7.16 Rare Disease Therapeutics
7.16.1 Rare Disease Therapeutics Details
7.16.2 Rare Disease Therapeutics Major Business
7.16.3 Rare Disease Therapeutics Antiserum Product and Services
7.16.4 Rare Disease Therapeutics Antiserum Revenue, Gross Margin and Market Share (2018-2023)
7.16.5 Rare Disease Therapeutics Recent Developments/Updates
7.16.6 Rare Disease Therapeutics Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Antiserum Industry Chain
8.2 Antiserum Upstream Analysis
8.3 Antiserum Midstream Analysis
8.4 Antiserum Downstream Analysis
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF TABLES
Table 1. World Antiserum Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
Table 2. World Antiserum Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
Table 3. World Antiserum Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
Table 4. World Antiserum Revenue Market Share by Region (2018-2023), (by Headquarter Location)
Table 5. World Antiserum Revenue Market Share by Region (2024-2029), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Antiserum Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
Table 8. World Antiserum Consumption Value by Region (2018-2023) & (USD Million)
Table 9. World Antiserum Consumption Value Forecast by Region (2024-2029) & (USD Million)
Table 10. World Antiserum Revenue by Player (2018-2023) & (USD Million)
Table 11. Revenue Market Share of Key Antiserum Players in 2022
Table 12. World Antiserum Industry Rank of Major Player, Based on Revenue in 2022
Table 13. Global Antiserum Company Evaluation Quadrant
Table 14. Head Office of Key Antiserum Player
Table 15. Antiserum Market: Company Product Type Footprint
Table 16. Antiserum Market: Company Product Application Footprint
Table 17. Antiserum Mergers & Acquisitions Activity
Table 18. United States VS China Antiserum Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 19. United States VS China Antiserum Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 20. United States Based Antiserum Companies, Headquarters (States, Country)
Table 21. United States Based Companies Antiserum Revenue, (2018-2023) & (USD Million)
Table 22. United States Based Companies Antiserum Revenue Market Share (2018-2023)
Table 23. China Based Antiserum Companies, Headquarters (Province, Country)
Table 24. China Based Companies Antiserum Revenue, (2018-2023) & (USD Million)
Table 25. China Based Companies Antiserum Revenue Market Share (2018-2023)
Table 26. Rest of World Based Antiserum Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies Antiserum Revenue, (2018-2023) & (USD Million)
Table 28. Rest of World Based Companies Antiserum Revenue Market Share (2018-2023)
Table 29. World Antiserum Market Size by Type, (USD Million), 2018 & 2022 & 2029
Table 30. World Antiserum Market Size by Type (2018-2023) & (USD Million)
Table 31. World Antiserum Market Size by Type (2024-2029) & (USD Million)
Table 32. World Antiserum Market Size by Application, (USD Million), 2018 & 2022 & 2029
Table 33. World Antiserum Market Size by Application (2018-2023) & (USD Million)
Table 34. World Antiserum Market Size by Application (2024-2029) & (USD Million)
Table 35. BD Basic Information, Area Served and Competitors
Table 36. BD Major Business
Table 37. BD Antiserum Product and Services
Table 38. BD Antiserum Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 39. BD Recent Developments/Updates
Table 40. BD Competitive Strengths & Weaknesses
Table 41. Bio-Rad Basic Information, Area Served and Competitors
Table 42. Bio-Rad Major Business
Table 43. Bio-Rad Antiserum Product and Services
Table 44. Bio-Rad Antiserum Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 45. Bio-Rad Recent Developments/Updates
Table 46. Bio-Rad Competitive Strengths & Weaknesses
Table 47. Shanghai Serum Bio-Technology Co., Ltd. Basic Information, Area Served and Competitors
Table 48. Shanghai Serum Bio-Technology Co., Ltd. Major Business
Table 49. Shanghai Serum Bio-Technology Co., Ltd. Antiserum Product and Services
Table 50. Shanghai Serum Bio-Technology Co., Ltd. Antiserum Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 51. Shanghai Serum Bio-Technology Co., Ltd. Recent Developments/Updates
Table 52. Shanghai Serum Bio-Technology Co., Ltd. Competitive Strengths & Weaknesses
Table 53. China National Pharmaceutical Group Basic Information, Area Served and Competitors
Table 54. China National Pharmaceutical Group Major Business
Table 55. China National Pharmaceutical Group Antiserum Product and Services
Table 56. China National Pharmaceutical Group Antiserum Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 57. China National Pharmaceutical Group Recent Developments/Updates
Table 58. China National Pharmaceutical Group Competitive Strengths & Weaknesses
Table 59. CSL Basic Information, Area Served and Competitors
Table 60. CSL Major Business
Table 61. CSL Antiserum Product and Services
Table 62. CSL Antiserum Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 63. CSL Recent Developments/Updates
Table 64. CSL Competitive Strengths & Weaknesses
Table 65. Merck Basic Information, Area Served and Competitors
Table 66. Merck Major Business
Table 67. Merck Antiserum Product and Services
Table 68. Merck Antiserum Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 69. Merck Recent Developments/Updates
Table 70. Merck Competitive Strengths & Weaknesses
Table 71. BTG Basic Information, Area Served and Competitors
Table 72. BTG Major Business
Table 73. BTG Antiserum Product and Services
Table 74. BTG Antiserum Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 75. BTG Recent Developments/Updates
Table 76. BTG Competitive Strengths & Weaknesses
Table 77. Pfizer Basic Information, Area Served and Competitors
Table 78. Pfizer Major Business
Table 79. Pfizer Antiserum Product and Services
Table 80. Pfizer Antiserum Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 81. Pfizer Recent Developments/Updates
Table 82. Pfizer Competitive Strengths & Weaknesses
Table 83. Haffkine Bio-Pharmaceutical Basic Information, Area Served and Competitors
Table 84. Haffkine Bio-Pharmaceutical Major Business
Table 85. Haffkine Bio-Pharmaceutical Antiserum Product and Services
Table 86. Haffkine Bio-Pharmaceutical Antiserum Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 87. Haffkine Bio-Pharmaceutical Recent Developments/Updates
Table 88. Haffkine Bio-Pharmaceutical Competitive Strengths & Weaknesses
Table 89. Vins Bioproducts Basic Information, Area Served and Competitors
Table 90. Vins Bioproducts Major Business
Table 91. Vins Bioproducts Antiserum Product and Services
Table 92. Vins Bioproducts Antiserum Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 93. Vins Bioproducts Recent Developments/Updates
Table 94. Vins Bioproducts Competitive Strengths & Weaknesses
Table 95. Bharat Serums and Vaccines Basic Information, Area Served and Competitors
Table 96. Bharat Serums and Vaccines Major Business
Table 97. Bharat Serums and Vaccines Antiserum Product and Services
Table 98. Bharat Serums and Vaccines Antiserum Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 99. Bharat Serums and Vaccines Recent Developments/Updates
Table 100. Bharat Serums and Vaccines Competitive Strengths & Weaknesses
Table 101. SSI Diagnostica Basic Information, Area Served and Competitors
Table 102. SSI Diagnostica Major Business
Table 103. SSI Diagnostica Antiserum Product and Services
Table 104. SSI Diagnostica Antiserum Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 105. SSI Diagnostica Recent Developments/Updates
Table 106. SSI Diagnostica Competitive Strengths & Weaknesses
Table 107. GD Animal Health Basic Information, Area Served and Competitors
Table 108. GD Animal Health Major Business
Table 109. GD Animal Health Antiserum Product and Services
Table 110. GD Animal Health Antiserum Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 111. GD Animal Health Recent Developments/Updates
Table 112. GD Animal Health Competitive Strengths & Weaknesses
Table 113. MicroPharm Basic Information, Area Served and Competitors
Table 114. MicroPharm Major Business
Table 115. MicroPharm Antiserum Product and Services
Table 116. MicroPharm Antiserum Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 117. MicroPharm Recent Developments/Updates
Table 118. MicroPharm Competitive Strengths & Weaknesses
Table 119. Peptide Institute Inc. Basic Information, Area Served and Competitors
Table 120. Peptide Institute Inc. Major Business
Table 121. Peptide Institute Inc. Antiserum Product and Services
Table 122. Peptide Institute Inc. Antiserum Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 123. Peptide Institute Inc. Recent Developments/Updates
Table 124. Rare Disease Therapeutics Basic Information, Area Served and Competitors
Table 125. Rare Disease Therapeutics Major Business
Table 126. Rare Disease Therapeutics Antiserum Product and Services
Table 127. Rare Disease Therapeutics Antiserum Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 128. Global Key Players of Antiserum Upstream (Raw Materials)
Table 129. Antiserum Typical Customers
Table 1. World Antiserum Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
Table 2. World Antiserum Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
Table 3. World Antiserum Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
Table 4. World Antiserum Revenue Market Share by Region (2018-2023), (by Headquarter Location)
Table 5. World Antiserum Revenue Market Share by Region (2024-2029), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Antiserum Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
Table 8. World Antiserum Consumption Value by Region (2018-2023) & (USD Million)
Table 9. World Antiserum Consumption Value Forecast by Region (2024-2029) & (USD Million)
Table 10. World Antiserum Revenue by Player (2018-2023) & (USD Million)
Table 11. Revenue Market Share of Key Antiserum Players in 2022
Table 12. World Antiserum Industry Rank of Major Player, Based on Revenue in 2022
Table 13. Global Antiserum Company Evaluation Quadrant
Table 14. Head Office of Key Antiserum Player
Table 15. Antiserum Market: Company Product Type Footprint
Table 16. Antiserum Market: Company Product Application Footprint
Table 17. Antiserum Mergers & Acquisitions Activity
Table 18. United States VS China Antiserum Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 19. United States VS China Antiserum Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 20. United States Based Antiserum Companies, Headquarters (States, Country)
Table 21. United States Based Companies Antiserum Revenue, (2018-2023) & (USD Million)
Table 22. United States Based Companies Antiserum Revenue Market Share (2018-2023)
Table 23. China Based Antiserum Companies, Headquarters (Province, Country)
Table 24. China Based Companies Antiserum Revenue, (2018-2023) & (USD Million)
Table 25. China Based Companies Antiserum Revenue Market Share (2018-2023)
Table 26. Rest of World Based Antiserum Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies Antiserum Revenue, (2018-2023) & (USD Million)
Table 28. Rest of World Based Companies Antiserum Revenue Market Share (2018-2023)
Table 29. World Antiserum Market Size by Type, (USD Million), 2018 & 2022 & 2029
Table 30. World Antiserum Market Size by Type (2018-2023) & (USD Million)
Table 31. World Antiserum Market Size by Type (2024-2029) & (USD Million)
Table 32. World Antiserum Market Size by Application, (USD Million), 2018 & 2022 & 2029
Table 33. World Antiserum Market Size by Application (2018-2023) & (USD Million)
Table 34. World Antiserum Market Size by Application (2024-2029) & (USD Million)
Table 35. BD Basic Information, Area Served and Competitors
Table 36. BD Major Business
Table 37. BD Antiserum Product and Services
Table 38. BD Antiserum Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 39. BD Recent Developments/Updates
Table 40. BD Competitive Strengths & Weaknesses
Table 41. Bio-Rad Basic Information, Area Served and Competitors
Table 42. Bio-Rad Major Business
Table 43. Bio-Rad Antiserum Product and Services
Table 44. Bio-Rad Antiserum Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 45. Bio-Rad Recent Developments/Updates
Table 46. Bio-Rad Competitive Strengths & Weaknesses
Table 47. Shanghai Serum Bio-Technology Co., Ltd. Basic Information, Area Served and Competitors
Table 48. Shanghai Serum Bio-Technology Co., Ltd. Major Business
Table 49. Shanghai Serum Bio-Technology Co., Ltd. Antiserum Product and Services
Table 50. Shanghai Serum Bio-Technology Co., Ltd. Antiserum Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 51. Shanghai Serum Bio-Technology Co., Ltd. Recent Developments/Updates
Table 52. Shanghai Serum Bio-Technology Co., Ltd. Competitive Strengths & Weaknesses
Table 53. China National Pharmaceutical Group Basic Information, Area Served and Competitors
Table 54. China National Pharmaceutical Group Major Business
Table 55. China National Pharmaceutical Group Antiserum Product and Services
Table 56. China National Pharmaceutical Group Antiserum Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 57. China National Pharmaceutical Group Recent Developments/Updates
Table 58. China National Pharmaceutical Group Competitive Strengths & Weaknesses
Table 59. CSL Basic Information, Area Served and Competitors
Table 60. CSL Major Business
Table 61. CSL Antiserum Product and Services
Table 62. CSL Antiserum Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 63. CSL Recent Developments/Updates
Table 64. CSL Competitive Strengths & Weaknesses
Table 65. Merck Basic Information, Area Served and Competitors
Table 66. Merck Major Business
Table 67. Merck Antiserum Product and Services
Table 68. Merck Antiserum Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 69. Merck Recent Developments/Updates
Table 70. Merck Competitive Strengths & Weaknesses
Table 71. BTG Basic Information, Area Served and Competitors
Table 72. BTG Major Business
Table 73. BTG Antiserum Product and Services
Table 74. BTG Antiserum Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 75. BTG Recent Developments/Updates
Table 76. BTG Competitive Strengths & Weaknesses
Table 77. Pfizer Basic Information, Area Served and Competitors
Table 78. Pfizer Major Business
Table 79. Pfizer Antiserum Product and Services
Table 80. Pfizer Antiserum Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 81. Pfizer Recent Developments/Updates
Table 82. Pfizer Competitive Strengths & Weaknesses
Table 83. Haffkine Bio-Pharmaceutical Basic Information, Area Served and Competitors
Table 84. Haffkine Bio-Pharmaceutical Major Business
Table 85. Haffkine Bio-Pharmaceutical Antiserum Product and Services
Table 86. Haffkine Bio-Pharmaceutical Antiserum Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 87. Haffkine Bio-Pharmaceutical Recent Developments/Updates
Table 88. Haffkine Bio-Pharmaceutical Competitive Strengths & Weaknesses
Table 89. Vins Bioproducts Basic Information, Area Served and Competitors
Table 90. Vins Bioproducts Major Business
Table 91. Vins Bioproducts Antiserum Product and Services
Table 92. Vins Bioproducts Antiserum Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 93. Vins Bioproducts Recent Developments/Updates
Table 94. Vins Bioproducts Competitive Strengths & Weaknesses
Table 95. Bharat Serums and Vaccines Basic Information, Area Served and Competitors
Table 96. Bharat Serums and Vaccines Major Business
Table 97. Bharat Serums and Vaccines Antiserum Product and Services
Table 98. Bharat Serums and Vaccines Antiserum Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 99. Bharat Serums and Vaccines Recent Developments/Updates
Table 100. Bharat Serums and Vaccines Competitive Strengths & Weaknesses
Table 101. SSI Diagnostica Basic Information, Area Served and Competitors
Table 102. SSI Diagnostica Major Business
Table 103. SSI Diagnostica Antiserum Product and Services
Table 104. SSI Diagnostica Antiserum Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 105. SSI Diagnostica Recent Developments/Updates
Table 106. SSI Diagnostica Competitive Strengths & Weaknesses
Table 107. GD Animal Health Basic Information, Area Served and Competitors
Table 108. GD Animal Health Major Business
Table 109. GD Animal Health Antiserum Product and Services
Table 110. GD Animal Health Antiserum Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 111. GD Animal Health Recent Developments/Updates
Table 112. GD Animal Health Competitive Strengths & Weaknesses
Table 113. MicroPharm Basic Information, Area Served and Competitors
Table 114. MicroPharm Major Business
Table 115. MicroPharm Antiserum Product and Services
Table 116. MicroPharm Antiserum Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 117. MicroPharm Recent Developments/Updates
Table 118. MicroPharm Competitive Strengths & Weaknesses
Table 119. Peptide Institute Inc. Basic Information, Area Served and Competitors
Table 120. Peptide Institute Inc. Major Business
Table 121. Peptide Institute Inc. Antiserum Product and Services
Table 122. Peptide Institute Inc. Antiserum Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 123. Peptide Institute Inc. Recent Developments/Updates
Table 124. Rare Disease Therapeutics Basic Information, Area Served and Competitors
Table 125. Rare Disease Therapeutics Major Business
Table 126. Rare Disease Therapeutics Antiserum Product and Services
Table 127. Rare Disease Therapeutics Antiserum Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 128. Global Key Players of Antiserum Upstream (Raw Materials)
Table 129. Antiserum Typical Customers
LIST OF FIGURES
Figure 1. Antiserum Picture
Figure 2. World Antiserum Total Market Size: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Antiserum Total Market Size (2018-2029) & (USD Million)
Figure 4. World Antiserum Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
Figure 5. World Antiserum Revenue Market Share by Region (2018-2029), (by Headquarter Location)
Figure 6. United States Based Company Antiserum Revenue (2018-2029) & (USD Million)
Figure 7. China Based Company Antiserum Revenue (2018-2029) & (USD Million)
Figure 8. Europe Based Company Antiserum Revenue (2018-2029) & (USD Million)
Figure 9. Japan Based Company Antiserum Revenue (2018-2029) & (USD Million)
Figure 10. South Korea Based Company Antiserum Revenue (2018-2029) & (USD Million)
Figure 11. ASEAN Based Company Antiserum Revenue (2018-2029) & (USD Million)
Figure 12. India Based Company Antiserum Revenue (2018-2029) & (USD Million)
Figure 13. Antiserum Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Antiserum Consumption Value (2018-2029) & (USD Million)
Figure 16. World Antiserum Consumption Value Market Share by Region (2018-2029)
Figure 17. United States Antiserum Consumption Value (2018-2029) & (USD Million)
Figure 18. China Antiserum Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe Antiserum Consumption Value (2018-2029) & (USD Million)
Figure 20. Japan Antiserum Consumption Value (2018-2029) & (USD Million)
Figure 21. South Korea Antiserum Consumption Value (2018-2029) & (USD Million)
Figure 22. ASEAN Antiserum Consumption Value (2018-2029) & (USD Million)
Figure 23. India Antiserum Consumption Value (2018-2029) & (USD Million)
Figure 24. Producer Shipments of Antiserum by Player Revenue ($MM) and Market Share (%): 2022
Figure 25. Global Four-firm Concentration Ratios (CR4) for Antiserum Markets in 2022
Figure 26. Global Four-firm Concentration Ratios (CR8) for Antiserum Markets in 2022
Figure 27. United States VS China: Antiserum Revenue Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Antiserum Consumption Value Market Share Comparison (2018 & 2022 & 2029)
Figure 29. World Antiserum Market Size by Type, (USD Million), 2018 & 2022 & 2029
Figure 30. World Antiserum Market Size Market Share by Type in 2022
Figure 31. Antitoxin Serum
Figure 32. Antibacterial Serum
Figure 33. Antiviral Serum
Figure 34. Others
Figure 35. World Antiserum Market Size Market Share by Type (2018-2029)
Figure 36. World Antiserum Market Size by Application, (USD Million), 2018 & 2022 & 2029
Figure 37. World Antiserum Market Size Market Share by Application in 2022
Figure 38. Clinical
Figure 39. Laboratory
Figure 40. Antiserum Industrial Chain
Figure 41. Methodology
Figure 42. Research Process and Data Source
Figure 1. Antiserum Picture
Figure 2. World Antiserum Total Market Size: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Antiserum Total Market Size (2018-2029) & (USD Million)
Figure 4. World Antiserum Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
Figure 5. World Antiserum Revenue Market Share by Region (2018-2029), (by Headquarter Location)
Figure 6. United States Based Company Antiserum Revenue (2018-2029) & (USD Million)
Figure 7. China Based Company Antiserum Revenue (2018-2029) & (USD Million)
Figure 8. Europe Based Company Antiserum Revenue (2018-2029) & (USD Million)
Figure 9. Japan Based Company Antiserum Revenue (2018-2029) & (USD Million)
Figure 10. South Korea Based Company Antiserum Revenue (2018-2029) & (USD Million)
Figure 11. ASEAN Based Company Antiserum Revenue (2018-2029) & (USD Million)
Figure 12. India Based Company Antiserum Revenue (2018-2029) & (USD Million)
Figure 13. Antiserum Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Antiserum Consumption Value (2018-2029) & (USD Million)
Figure 16. World Antiserum Consumption Value Market Share by Region (2018-2029)
Figure 17. United States Antiserum Consumption Value (2018-2029) & (USD Million)
Figure 18. China Antiserum Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe Antiserum Consumption Value (2018-2029) & (USD Million)
Figure 20. Japan Antiserum Consumption Value (2018-2029) & (USD Million)
Figure 21. South Korea Antiserum Consumption Value (2018-2029) & (USD Million)
Figure 22. ASEAN Antiserum Consumption Value (2018-2029) & (USD Million)
Figure 23. India Antiserum Consumption Value (2018-2029) & (USD Million)
Figure 24. Producer Shipments of Antiserum by Player Revenue ($MM) and Market Share (%): 2022
Figure 25. Global Four-firm Concentration Ratios (CR4) for Antiserum Markets in 2022
Figure 26. Global Four-firm Concentration Ratios (CR8) for Antiserum Markets in 2022
Figure 27. United States VS China: Antiserum Revenue Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Antiserum Consumption Value Market Share Comparison (2018 & 2022 & 2029)
Figure 29. World Antiserum Market Size by Type, (USD Million), 2018 & 2022 & 2029
Figure 30. World Antiserum Market Size Market Share by Type in 2022
Figure 31. Antitoxin Serum
Figure 32. Antibacterial Serum
Figure 33. Antiviral Serum
Figure 34. Others
Figure 35. World Antiserum Market Size Market Share by Type (2018-2029)
Figure 36. World Antiserum Market Size by Application, (USD Million), 2018 & 2022 & 2029
Figure 37. World Antiserum Market Size Market Share by Application in 2022
Figure 38. Clinical
Figure 39. Laboratory
Figure 40. Antiserum Industrial Chain
Figure 41. Methodology
Figure 42. Research Process and Data Source
